ADIPOQ and obesity disorder: This requires integrating data from dynamic biomarker monitoring (including adiponectin isoforms), clinical characteristics (obesity status, baseline metabolic health), genetic factors, inflammatory phenotypes (e.g., based on cytokine profiles), and the specific stage or trajectory of sepsis.